 | Up a level |
Dukanya and Shanmugam, M. K. and Shobith, R. and Metri, P. K. and Mohan, S. and Basappa and Rangappa, K. S. (2020) Anti-proliferative activity and characterization data on oxadiazole derivatives. Data in Brief, 31.
Somu, C. and Mohan, C. D. and Ambekar, Sachin and Dukanya and Shobith, R. and Baburajeev, C. P. and Sukhorukov, A. and Mishra, S. and Shanmugam, M. K. and Chinnathambi, A. and Awad Alahmadi, T. and Alharbi, S. A. and Basappa and Rangappa, K. S. (2020) Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells. Biotechnology Reports, 25. ISSN 2215-017X
Mohan, C. D. and Anilkumar, N. C. and Rangappa, S. and Shanmugam, M. K. and Mishra, S. and Chinnathambi, A. and Alharbi, S. A. and Bhattacharjee, Atanu and Sethi, G. and Kumar, A. P. and Basappa and Rangappa, K. S. (2018) Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-KB in hepatocellular carcinoma cells. Frontiers in Oncology, 8 (42).
Mohan, C. D. and Bharathkumar, H. and Bulusu, K. C. and Pandey, Vijay and Shobith, R. and Fuchs, Julian E. and Shanmugam, M. K. and Dai, Xiaoyun and Li, Feng and Amudha Deivasigamani and Hui, Kam M. and Prem Kumar, A. and Lobie, Peter E. and Bender, Andreas and Basappa, S. and Sethi, G. and Rangappa, K. S. (2014) Development of a novel azaspirane that targets the Janus kinase-signal Transducer and Activator of Transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo. Journal of Biological Chemistry, 289 (49). pp. 34296-34307.
